| Bioactivity | Adenosine 5'-diphosphate-13C10 (Adenosine diphosphate-13C10 dilithium; ADP-13C10) dilithium is 13C-labeled Adenosine 5'-diphosphate (HY-W010918). Adenosine 5'-diphosphate (Adenosine diphosphate) is a nucleoside diphosphate. Adenosine 5'-diphosphate is the product of ATP dephosphorylation by ATPases. Adenosine 5'-diphosphate induces human platelet aggregation and inhibits stimulated adenylate cyclase by an action at P2T-purinoceptors. |
| Invitro | 氢、碳和其他元素的稳定重同位素已被纳入药物分子中，主要作为药物开发过程中定量的示踪剂。氘化引起了人们的关注，因为它可能影响药物的药代动力学和代谢谱[1]。 0 --> Adenosine 5'-diphosphate-13C10 dilithium 相关抗体: |
| Name | Adenosine 5'-diphosphate-13C10 dilithium |
| Formula | 13C10H13Li2N5O10P2 |
| Molar Mass | 448.99 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. [2]. Arts IC, et al. Adenosine 5'-triphosphate (ATP) supplements are not orally bioavailable: a randomized, placebo-controlled cross-over trial in healthy humans. J Int Soc Sports Nutr. 2012 Apr 17;9(1):16. [3]. Noel J. Cusack, et al. Effects of phosphate-modified analogs of adenosine 5′-diphosphate and adenosine 5′‐triphosphate at P2T-purinoceptors mediating human platelet activation by ADP. April 1996. [4]. Adenosine-5'-diphosphate |
Adenosine 5'-diphosphate-13C10 dilithium
CAS: F: 13C10H13Li2N5O10P2 W: 448.99
Adenosine 5'-diphosphate-13C10 (Adenosine diphosphate-13C10 dilithium; ADP-13C10) dilithium is 13C-labeled Adenosine 5'-
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.